Subsequent research indicated that WT1 might play an oncologic role in hematologic malignancies and a variety of solid tumors, including leukemia, breast cancer, ovarian cancer, glioblastoma and soft tissue sarcoma, etc5, 6, 7, 8, 9. This evidence concerns the gene WT1 and ovarian cancer.